Atlas Trials

The Performance of Cancer Risk Genes in the Necessity of Secondary TURBT

Clinical trial NCT05112523 · UNKNOWN

Trial details

NCT number
NCT05112523
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
UNKNOWN
Study type
OBSERVATIONAL
Bladder Cancer
Start date
2020-12-20
Primary completion
2022-08-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.